Metamorworks/iStock.
The system, named Cas13D-N2V8, showed a significant reduction in the number of off-target genes and no detectable collateral damage in cell lines and somatic cells, which indicated its future potential, according to a report published in South China Morning Post newspaper on Wednesday.
Comments are closed.